-

Orthofix Launches Nationwide Recycling Program to Improve Sustainability

Orthofix is the first and only company in the U.S. to offer a free recycling program to its bone growth therapy patients

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the launch of a nationwide recycling program to improve sustainability efforts. Orthofix is the first and only company in the U.S. to offer a free recycling program so patients can properly dispose of their Bone Growth Therapy devices after use. The innovative program enables Orthofix patients to recycle their devices for non-medical use once they complete treatment.

Orthofix’s new program provides patients with instructions and prepaid shipping to send their used PhysioStim™, CervicalStim™ and SpinalStim™ therapy devices to Orthofix’s recycling partner to recycle the materials and components in the device for non-medical use. These devices, like others in their category, can be disposed of incorrectly, and it is Orthofix’s goal to create an easy to use pathway to facilitate recycling.

“As the leader in the bone growth stimulation market, we are proud to launch this ground-breaking recycling system and reduce our environmental impact,” said Kevin Kenny, President of Global Spine. “At Orthofix, we are committed to being a good corporate citizen. We are dedicated to promoting environmental sustainability in the conduct of our business. We know we can make a difference by working together with our patients and our suppliers.”

“As a former SpinalStim patient, I’m thrilled that Orthofix is recycling its bone growth therapy devices and helping to make a difference with the environment,” said Tamie, a triathlete who used her SpinalStim device following scoliosis surgery. “I appreciate that companies like Orthofix are doing their part to help improve the lives of their patients and our planet.”

Once a physician advises the patient to discontinue product use after treatment is completed, the patient is encouraged to contact Orthofix patient services. Patients are provided with a pre-paid return label so that they can box up the device, attach the return label, and mail the box to our recycling partner. To learn more about this recycling program, visit our website.

Since 1986, Orthofix Bone Growth Therapy has helped promote the natural bone-healing process in patients. Orthofix bone growth therapy devices provide a safe, noninvasive treatment that helps promote healing in fractured bones and spinal fusions that have not healed or have difficulty healing. The devices stimulate the bone’s natural healing process by sending low-level pulses of electromagnetic energy to the injury or fusion site.

About Orthofix

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company’s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patients’ lives. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors. For more information, please visit www.Orthofix.com.

Contacts

Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com

Guy Davis
Media Relations
Tel 214 937 3137
guydavis@orthofix.com

Orthofix Medical Inc. Logo
Orthofix Medical Inc. Logo

Orthofix Medical Inc.

NASDAQ:OFIX

Release Summary
Orthofix launches recycling initiative for its bone growth therapy devices, becoming the first and only company in the U.S. to offer such a program.
Release Versions

Contacts

Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com

Guy Davis
Media Relations
Tel 214 937 3137
guydavis@orthofix.com

Social Media Profiles
More News From Orthofix Medical Inc.

Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net sales and non-GAAP adjusted EBITDA guidance. Unless otherwise noted, pro forma results exclude the impact of the discontinued M6™ product lines. Third Quarter 2026 Highlights Total reported net sales of $207.9 million, representing an increase of 1% on a reported b...

Orthofix to Report Third Quarter 2026 Financial Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing 833-461-5787 in the U.S., and 585-542-9983 in all other locations, and referencing th...

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. Highlights Second quart...
Back to Newsroom